GRDN
Guardian Pharmacy Services Inc · Health Care
$42.17▲ $1.32 (3.24%) todayMarket open
Price
Live from the market
▲ $3.13 (8.00%) past month
Key Statistics
This session and the business
- Open$41.10
- High$42.44
- Low$40.86
- Previous close$40.84
- Volume100,831
- Market cap$2.59B
- Price to earnings39.19
- Earnings per share$1.02
- 52 week range$23.14 to $48.33
- Beta0.46
- Dividend yieldNone
The Desk and GRDN
What this desk has done with it
The desk has not traded GRDN yet. Suggest it on the Live Desk.
The Numbers
As reported to the SEC
RevenueNet income
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | $736.0M | $792.1M | $908.9M | $1.05B | $1.23B | $1.45B |
| Gross profit | $147.0M | $161.3M | $185.9M | $208.3M | $244.4M | $292.7M |
| Operating income | $32.1M | $30.1M | $52.0M | $40.9M | -$62.9M | $72.7M |
| Net income | $19.9M | $16.3M | $35.4M | $0 | -$110.0M | $49.2M |
| EPS (diluted) | — | $163140.00 | $354210.00 | $0.00 | -$1.77 | $0.78 |
Earnings
Next report 2026-11-09
Reported earnings per share, last 8 quarters.
Over the Years
Valuation and margin
| Year | P/E | Net Margin | ROE |
|---|---|---|---|
| 2025 | 38.6 | 3.4% | 26.6% |
| 2024 | — | -5.8% | -67.7% |
| 2023 | — | 3.6% | 55.6% |
| 2022 | — | 5.5% | 76.8% |
| 2021 | — | 3.6% | 47.1% |
| 2020 | — | 4.0% | 47.8% |
What Analysts Say
12 covering, 2026-09-01
- Buy11
- Hold1
- Sell0
News
Recent coverage
- Zacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBFYahoo · 3d ago
- Bet on Winning DuPont Analysis & Pick 5 Top StocksYahoo · 4d ago
- Guardian Pharmacy Services: Slowing Growth In H2 2026SeekingAlpha · 6d ago
- Keybanc Initiates Coverage of Guardian Pharmacy Services at OverweightFintel · 9d ago
- This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For WednesdayBenzinga · 9d ago
- Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52Benzinga · 9d ago
- Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51Benzinga · 11d ago
Insider Moves
Filed with the SEC
- Randall LewisDirectorbought 4,028 shares2026-05-05
- Steve CoslerDirectorbought 4,028 shares2026-05-05
- Mary Sue PatchettDirectorbought 4,028 shares2026-05-05
- Fred BurkePresident and Chief Executive Officersold 1,298,826 shares2026-03-28
- David MorrisExecutive Vice President and Chief Financial Officerbought 641,869 shares2026-03-28
- David MorrisExecutive Vice President and Chief Financial Officersold 641,869 shares2026-03-28
- Thomas Salentine, Jr.Director, Beneficial Ownerbought 6,100,175 shares2026-03-28
- Thomas Salentine, Jr.Director, Beneficial Ownersold 6,100,175 shares2026-03-28
Filings
Straight from EDGAR
- 8-K Current Report2026-09-10
- 10-Q Interim Report2026-08-06
- 8-K Current Report2026-08-06
- 8-K Earnings Press Release2026-08-06
- 8-K Current Report2026-06-22
- 8-K Current Report2026-06-22
- 8-K Current Report2026-05-28
- 8-K Current Report2026-05-07
Related
Others in the same business